GSK - GlaxoSmithKline plc (via Public) / GSK receives CHMP p

GSK - GlaxoSmithKline plc (via Public) / GSK receives CHMP positive opinions recommending approval of Nucala (mepolizumab) in three additional eosinophil-driven diseases